28/02/2026 Other Services
The landscape of clinical research has expanded significantly beyond the controlled environment of randomised clinical trials. As the industry seeks to understand how treatments perform in broader patient populations, the reliance on observational data has grown.
However, the transition from raw data to actionable insight is fraught with challenges. A significant number of projects do not achieve their objectives, not due to a lack of data, but due to a lack of structure. This is why robust data governance, specifically led by Clinical Research Organisations (CROs), has become a critical success factor for Real World Evidence Studies.
The landscape of clinical research has expanded significantly beyond the controlled environment of randomised clinical trials. As the industry seeks t...
India’s pharmaceutical industry is changing fast. Patients are more informed. Regulators expect stronger proof. Healthcare systems are focusing on out...
The problem isn’t AI itself, it's how people use it. This article breaks down why most AI-generated content lacks differentiation, authority signals, ...
The supply chain is the backbone of global commerce, but in today’s world, it faces increasing challenges such as fluctuating demand, geopolitical unc...
More Details